Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions.
Lucas
L
Goossens
Baudouin
B
Standaert
Nico
N
Hartwig
Anke M
AM
Hövels
Maiwenn J
MJ
Al
D003362:Cost-Benefit Analysis; D006801:Humans; D009426:Netherlands; D012400:Rotavirus Infections / Q000191:economics* / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000191:economics* / Q000276:immunology*; D014611:Vaccination / Q000191:economics* / Q000706:statistics & numerical data*
D022243:Rotavirus Vaccines